![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Letter from the President
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Jacques Banchereau, PhD |
Vijay Kuchroo, DVM, PhD |
Arlene Sharpe, MD, PhD |
Terri Laufer, MD |
Kathryn Wood, PhD |
Joan Governman, PhD |
You may now view FOCIS 2008 abstracts online at http://www.focisnet.org/meetings/am08/. Please select “Abstracts Online” from the menu.
As you may know, the FOCIS 2008 evaluation system went “green” this year by eliminating the thousands of sheets of paper used by printing evaluations and replacing them with an online site that allows you to print your CME or Attendance Certificate from home. Your feedback is an essential part of the planning for future education. If you have not already, please take the time to complete the evaluations online at http://data.express-evaluations.com/eval/37190/web/main.php.
Smile! Please visit the FOCIS 2008 website at http://www.focisnet.org/meetings/am08/ and click on the “Photos Gallery” link to check it out.
The FOCIS Network of Consortia (NOC) united for their 4th annual meeting and 2nd annual presentation at FOCIS 2008. This important initiative provides a forum for representatives from genetic consortia in the major areas of immune-mediated disease to meet, share data and discuss findings. The combined genome-wide association scan data is currently under review for publication in major journals and the network looks forward to the addition of new disease areas that are ready to contribute data. For more information about how to become involved please send inquires to info@focisnet.org.
FOCIS Industry Liaison Council
![]() |
![]() |
![]() |
![]() |
![]() ![]() ![]() ![]() ![]() |
|||
FOCIS 2008 Major Supporters
![]() |
![]() |
![]() |
![]() |
![]() ![]() ![]() ![]() ![]() |
|||
FOCIS 2008 Contributing Supporters
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||
![]() |
If you missed FOCIS 2008 or you liked it so much that you plan on being an annual delegate, please note that the next meeting will be held: FOCIS 2009
|
Every year each of the 51 FOCIS Centers of Excellence (FCE) selects the top two trainees from their center whose research features interdisciplinary science. These trainees receive complimentary FOCIS 2008 registration and a travel award to attend the meeting. 50 trainees participated in this year’s symposium. Ten oral presentations were selected and all trainees prepared a poster for presentation at the evening reception.
A new addition to this year’s symposium was the Poster Teaser session. Trainees had one minute and one slide to entice the audience to visit their posters later in the evening. Both the Poster Teasers and the Poster Session were judged and winners were recognized at the evening Poster Reception.
Congratulations to all TSS participants including…![]() |
Oral Abstract Presenters |
|
Poster Teaser Winner Poster Session Winners |
![]() |
FOCIS 2008 hosted to two FOCIS Educational Programs. The long-standing course, Basic Immunology in Medicine: Update 2008 and the new Interventional Immunology course were both oversubscribed with attendance over 150 people each. Delegates were given the option to take the courses individually or to attend both for a discounted rate. Over half of the delegates opted for the package to begin with the Basic course and build upon it with the Interventional course the next day. |
![]() |
||
| Both courses will be offered again in the same manner at FOCIS 2009 in San Francisco. We look forward to seeing you there! The next FOCIS educational opportunity is the 2009 Advanced Course in Basic & Clinical Immunology. The course will be held: | ||||
|
|
February 18-22, 2009 Mondrian Scottsdale, Arizona, USA |
![]() |
|
Students in this course include clinical fellows, trainees in the pharmaceutical industry, and practicing academic physicians who find the need to enhance their understanding of immunology. Invited speakers lecture on the major topics in cellular and molecular immunology, including innate immunity, B cells, T cells, and cytokines. There will be ample opportunity for students to interact with the faculty outside the lecture room. Mark your calendars and register early – registration opens October 15, 2008 online at www.focisnet.org! |
||||
According to Dr. Ted Schlaegel, in approximately 1963, he began inviting people to his hotel room during national ophthalmic meetings for discussions about uveitis. This "Informal Uveitis Club," was initially attended by 2-4 people. Because of increasing attendance, the first formal meeting was held on September 26, 1972. The "Informal Uveitis Club" continued through the 1976 American Academy of Ophthalmology (AAO) meeting. The group evolved into the American Uveitis Society at the 1977 AAO meeting. Membership was initially restricted to 40 people. The evolution into the AUS was nurtured and supported by Drs. Robert Coles (New York), David Knox (Baltimore), and Dick O'Connor (San Francisco).
The AUS began its further evolution into a larger, more structured organization in 1983 in response to suggestions by Dr. Rudolph Franklin from New Orleans. Key people involved in the transformation were Drs. Dick O'Connor, Howard Tessler (Chicago), Bob Nussenblatt (Bethesda, MD), Henry Kaplan (Louisville), and Ronald Smith (Los Angeles). Changes included opening the membership to approximately 100 members, establishing an Executive Committee, and incorporating. The transition was completed by 1990. The AUS has flourished since with meetings held at the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology meeting and a mid-winter gathering. It has become the premier group dealing with the disease in the United States.
Recent AUS Achievements:
![]() |
Center Director: Dominique Baeten FOCIS: What is the coolest way that you facilitate interdisciplinary research? Baeten: In our experience, the best way to facilitate interdisciplinary research is to organize cross-disciplinary meetings on clinical immunology. We do this at the local level in the Netherlands, but have also held a European Workshop on Immune-Mediated Inflammatory Diseases since 2006. The key to the success of this meeting is not only the interdisciplinary approach but also the small and interactive workshop format. At a time where it is still not clear what the European FCE exactly want to achieve, this meeting is a prime example of how we can create momentum around the FOCIS concept. |
FOCIS: Why do you dig immunology?
Baeten: Immunology touches the essence of life: how do we maintain our integrity but at the same time remain adapted to the external world? The solution lies in a system with a very high density of interactions between the different players, resulting in a very complex but robust and self-regulating structure. The beauty and challenge of clinical immunology is to recognize clinically relevant patterns within this complexity.
FOCIS: What’s your vision for the future of immunology?
Baeten: The future of immunology lies in clinical applications of our increasing understanding of how the immune system works. Besides the current boom of therapeutic monoclonal antibodies, the prime example here remains the enormous clinical impact of vaccination against infectious diseases. Of interest, it appears that the human brain did not really invent anything new here: in both examples, we just copied normal aspects of the immune system.
Welcome New Centers!
FOCIS and the FOCIS Centers of Excellence (FCE) extend a warm welcome to the newest members of the FCE network.
Institut Pasteur – Matthew Albert
The Feinstein Institute – Betty Diamond
October 2007 – September 2008
Oxford University, United Kingdom
June 26-27, 2008
Nantes, France
2008 International Conference
July 22-26, 2008
Florence, Italy
Collegio Lamaro Pozzani
July 28-August 8, 2008
Rome, Italy
July 30 - August 1, 2008
Mexico
August 4 - August 8, 2008
Mexico
August 10 - 14, 2008
Sydney, Australia
August 30 - September 2, 2008
Milan, Italy
September 7 - 9, 2008
Boston, Massachusetts, USA
Contact: Kate Fitzgerald at kfitzgerald2@partners.org
September 8 - 9, 2008
La Jolia, California, USA
September 13 - 20, 2008
Rio de Janeiro, Brazil
International meeting of the Americas, European and Latin American Committees for Treatment and Research of Multiple Sclerosis
September 17 - 20, 2008
Montreal, Quebec, Canada
October 27 - 31, 2008
Toronto, Ontario, Canada
November 19 - 22, 2008
Queen Sirikit National Convention Center, Bangkok, Thailand
July 5 -9 , 2009
Boston, Massachusetts, USA
September 24 – 27, 2009
New Paltz, NY, USA
November 2-6, 2009
San Francisco, California
August 22-27, 2010
Kobe, Japan
September 25 - 29, 2010
Hollywood, Florida
October 17 - 21, 2011
New Orleans, Louisiana
Post-Doctoral Position
Harvard Medical School/Brigham and Women's Hospital
Cutting edge projects focusing on the mechanisms of autoimmune disease/inflammation. These projects include novel pathways that regulate macrophages, and T cells, macrophage biology linked to lupus, determining the unique and shared role of the principle macrophage developmental molecule and its isoforms in immune mediated inflammation and lupus, the power of the specific programmed death pathways in regulating tissue injury, and an emphasis on the role of resident cells in regulating the immune response. Unique transgenic strains and knockout mice with reporter genes have been constructed on lupus susceptible strains for these projects. These projects dissect the basic mechanisms of autoimmune (skin, heart, kidney). Projects include human translational studies in patients with lupus. The ultimate goal is to identify potential therapeutic targets/ biomarkers for lupus and by extension other immune mediated diseases.
Experience:
Immunology, Molecular biology and/or Cell Biology
Knowledge of histopathology desirable
Mouse systems
Computer literacy is necessary
Desired:
Responsible, hard-working individual who is able to multi-task and to work independently. Position available immediately. MD, or PhD required, position for two years or longer within the Department of Medicine, Brigham and Women’s Hospital. Please send three references.
Interested candidates contact:
Dr. Vicki Rubin Kelley
Harvard Institutes of Medicine
4 Blackfan Circle
Boston, MA 02115
FAX 617-525-5830
e-mail: vkelley@rics.bwh.harvard.edu
Medical Science Liaison (MSL), based in a major East Coast city
Therakos, Inc., a member of Johnson & Johnson's Family of Companies
Therakos, Inc. specializes in extracorporeal immune cell therapies for the prevention and treatment of serious immune-mediated and neoplastic diseases. Therakos' proprietary procedures in photopheresis are used by physicians for the palliative treatment of the skin manifestations of cutaneous T-cell lymphoma.
The MSL will build advocacy for the Company Extracorporeal Apheresis treatment with opinion leaders, key academic centers and professional organizations in the Eastern U.S. Region. The MSL will serve as a scientific and clinical support resource for Company. This includes directly communicating scientific and medical information during interactions with health care practitioners and pre-clinical researchers. Topic areas include: Stem Cell Transplantation, Apheresis, Dermatology, Hematology, Oncology and Immunology.
PharmD, MD or PhD is required. At least 1 year of pharmaceutical or medical device industry experience preferred. Prior MSL experience is desirable. Therapeutic area experience in oncology, hematology, dermatology and/or immunology is highly preferred. Travel up to 70%. See full job description on our website.
As a valued team member, you’ll receive a competitive salary and great benefits including medical/dental, a 401(k), a pension plan and a comprehensive wellness program. If interested, please apply directly on-line at our web site www.jnj.com/careers noting Req. Code 0807143. The Johnson & Johnson Family of Companies has a strong commitment to diversity and welcomes applications for all individuals. EOE M/F/D/V
Senior Scientist Immunology (B Cell biology)
Merck Serono Geneva Research Center
Purpose of the Role:
This position requires an experienced scientist with a track record in the field of human B cell biology and a good understanding of clinical strategies that target B cells. You will be expected to use your knowledge and experience to mentor staff and to drive scientific innovation and capability within the Immunology Group.
Main tasks & Responsibilities:
In this role, you will be expected to:
Education & Languages:
Professional Skills & Experience:
Personal Skills & Competencies:
Senior Scientist Immunology (Cytokine biology)
Merck Serono Geneva Research Center
Purpose of the Role:
This position requires an experienced scientist with a track record in the field of cytokine biology and a good understanding of clinical strategies that target pro-inflammatory cytokines. You will be expected to use your knowledge and experience to mentor staff and to drive scientific innovation and capability within the Immunology Group.
Main tasks & Responsibilities:
In this role, you will be expected to:
Education & Languages:
Professional Skills & Experience:
Personal Skills & Competencies:
Senior Scientist Immunology (Inflammation)
Merck Serono Geneva Research Center
Purpose of the Role:
This position requires an experienced immunologist with a track record in the field of autoimmune and inflammatory diseases and a good understanding of clinical strategies targeting inflammatory pathways. Through close interaction with project managers and colleagues in other parts of the organization, the successful candidate will play a key role in our effort to establish and progress projects targeting inflammatory disorders, and to develop competencies in relevant area of Immunology.
Main Tasks & Responsibilities:
Education & Languages:
Professional Skills & Experience:
Personal Qualifications & Competencies:
Senior Scientist Immunology (T Cell Biology)
Merck Serono Geneva Research Center 0800387
Purpose of the Role:
This position requires an experienced immunologist with a track record in the field of T-cell biology as reflected by high quality publications and a good understanding of clinical strategies targeting T-cell responses.
Main Tasks & Responsibilities:
Education & Languages:
Professional Skills & Experience:
Personal Qualifications & Competencies:
Job postings should be 250 words or less and will remain on the website for 90 days. To post your opportunities please contact Sarah Krause.
FOCIS is a federation of societies that unite under the common mission to improve human health through immunology. American Academy of Allergy, Asthma and Immunology
• American College of Rheumatology |